Pfizer (PFE)

Add to Watchlists
Create an Alert
35.83 -0.37  -1.02% NYSE Oct 18, 16:20 Delayed 2m USD

Pfizer Research and Development Expense (Quarterly):

1.78B for June 30, 2017
View 4,000+ financial data types
Browse...
View Full Chart

Pfizer Research and Development Expense (Quarterly) Chart

Export Data
Save Image
Print Image

Pfizer Historical Research and Development Expense (Quarterly) Data

View and export this data going back to 1984. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2017 1.78B
March 31, 2017 1.708B
Dec. 31, 2016 2.512B
Sept. 30, 2016 1.881B
June 30, 2016 1.748B
March 31, 2016 1.731B
Dec. 31, 2015 2.348B
Sept. 30, 2015 1.722B
June 30, 2015 1.734B
March 31, 2015 1.885B
Dec. 31, 2014 3.209B
Sept. 30, 2014 1.802B
June 30, 2014 1.759B
March 31, 2014 1.623B
Dec. 31, 2013 1.811B
Sept. 30, 2013 1.627B
June 30, 2013 1.53B
March 31, 2013 1.71B
Dec. 31, 2012 2.021B
Sept. 30, 2012 1.887B
June 30, 2012 1.60B
March 31, 2012 2.062B
Dec. 31, 2011 2.194B
Sept. 30, 2011 2.176B
June 30, 2011 2.231B
   
March 31, 2011 2.091B
Dec. 31, 2010 2.893B
Sept. 30, 2010 2.188B
June 30, 2010 2.181B
March 31, 2010 2.221B
Dec. 31, 2009 2.813B
Sept. 30, 2009 1.632B
June 30, 2009 1.715B
March 31, 2009 1.705B
Dec. 31, 2008 2.936B
Sept. 30, 2008 1.885B
June 30, 2008 2.122B
March 31, 2008 1.791B
Dec. 31, 2007 2.26B
Sept. 30, 2007 1.999B
June 30, 2007 2.165B
March 31, 2007 1.665B
Dec. 31, 2006 2.412B
Sept. 30, 2006 1.902B
June 30, 2006 1.742B
March 31, 2006 1.543B
Dec. 31, 2005 1.969B
Sept. 30, 2005 1.739B
June 30, 2005 1.83B
March 31, 2005 1.764B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

Advertisement

PFE Research and Development Expense (Quarterly) Benchmarks

Companies
Abbott Laboratories 513.00M
Celgene 835.00M
Johnson & Johnson 2.574B

PFE Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 1.53B Jun 2013
Maximum 3.209B Dec 2014
Average 1.902B

PFE Research and Development Expense (Quarterly) Excel Add-In Codes

  • Metric Code: r_and_d_expense
  • Latest data point: =YCP("PFE", "r_and_d_expense")
  • Last 5 data points: =YCS("PFE", "r_and_d_expense", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.